Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-04

Clinical Trial Update: Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated a single IV abatacept dose in rheumatoid arthritis patients already receiving weekly SC abatacept to simulate a holiday; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: Rüdiger B. Müller | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED